Clinical trial
An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis
NCT00402688 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00402688 |
|---|---|
| Title | An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis |
| Official title | A Multicenter, Double-Blind, Phase 3B Study to Compare the Safety and Clinical Efficacy of Levofloxacin in 750mg for 2 Weeks and Levofloxacin 750mg for 3 Weeks to That of Levofloxacin 500mg for 4 Weeks in the Treatment of Chronic Prostatitis |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Collaborators | PriCara, Unit of Ortho-McNeil, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostatitis |
| Intervention type | Drug |
| Interventions | levofloxacin |
| Enrollment | 242 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Nov 22, 2006 |
| Last update posted | Sep 13, 2013 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: